Overview

A Study of LP-128 Capsules in Healthy Subjects

Status:
Not yet recruiting

Trial end date:
2022-07-30

Target enrollment:

Participant gender:

Summary

A Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of LP-128 Capsules After Single- and Multiple-Dose in Healthy Subjects

Phase:

Phase 1

Details

Lead Sponsor:

Guangzhou Lupeng Pharmaceutical Company LTD.